Suchergebnisse - "Dönnes, Pierre"

PubPharm (64)

1

Using serum metabolomics analysis to predict sub-clinical atherosclerosis in patients with SLE

enthalten in: bioRxiv.org | 2024

von Coelewij, L. | Waddington, K. | Robinson, G. | +12

2

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Peng, J. | Dönnes, P. | Ardoin, S. | +89

3

Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity

enthalten in: iScience | 2024

von Oppong, A. | Coelewij, L. | Robertson, G. | +7

4

The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice : An Ex Vivo and In Vivo Investigation

enthalten in: Cells | 2024

von Tejedor, S. | Wågberg, M. | Correia, C. | +13

5

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature

enthalten in: Arthritis & Rheumatology | 2024

von Peng, J. | Dönnes, P. | Ardoin, S. | +5

6

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis

enthalten in: Journal of neuroimmunology | 2022

von van der Weele, L. | Pollastro, S. | van Schaik, B. | +15

7

Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

enthalten in: Immunity, inflammation and disease | 2022

von Laurén, I. | Havervall, S. | Ng, H. | +28

8

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19

enthalten in: Journal of internal medicine | 2022

von Havervall, S. | Ng, H. | Jernbom Falk, A. | +27

9

Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

enthalten in: Immunity, Inflammation and Disease | 2022

von Laurén, I. | Havervall, S. | Ng, H. | +28

10

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

enthalten in: Journal of Internal Medicine | 2022

von Havervall, S. | Ng, H. | Jernbom Falk, A. | +27

1
2
3
4
5
6
7
Nächster »
[7]